<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04570774</url>
  </required_header>
  <id_info>
    <org_study_id>2020-06-068</org_study_id>
    <nct_id>NCT04570774</nct_id>
  </id_info>
  <brief_title>Effect of Cerebral and Cerebellar rTMS in Stroke Patient</brief_title>
  <official_title>Effect of Cerebral and Cerebellar Repetitive Transcranial Magnetic Stimulation on Motor Function in Stroke Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is based on the characteristics of motor learning theory and motor learning neural&#xD;
      network to improve motor function in stroke patients. This study is to investigate whether&#xD;
      the cerebral-cerebellar repetitive transcranial magnetic stimulation (rTMS) is effective in&#xD;
      improving motor function compared to the conventional cerebral rTMS in stroke patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2, 2020</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference of upper limb motor score in Fugl-Meyer assessment</measure>
    <time_frame>2 weeks</time_frame>
    <description>(upper limb motor score in Fugl-Meyer assessment at post-intervention) - (upper limb motor score in Fugl-Meyer assessment at baseline)&#xD;
Higher scores mean a better outcome</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Stroke</condition>
  <condition>Repetitive Transcranial Magnetic Stimulation</condition>
  <condition>rTMS</condition>
  <condition>Motor Recovery</condition>
  <arm_group>
    <arm_group_label>Facilitatory cerebral and cerebellar rTMS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients underwent 10 consecutive daily sessions of high-frequency repetitive transcranial magnetic stimulation (rTMS) over the affected primary motor cortex of the hand and high-frequency rTMS over the ipsilateral cerebellar hemisphere.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Facilitatory cerebral rTMS group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients underwent 10 consecutive daily sessions of high-frequency repetitive transcranial magnetic stimulation (rTMS) over the affected primary motor cortex of the hand and sham high-frequency rTMS over the ipsilateral cerebellar hemisphere.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inhibitory cerebral and cerebellar rTMS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients underwent 10 consecutive daily sessions of continous theta bust stimulation (cTBS) over the unaffected primary motor cortex of the hand and high-frequency rTMS over the ipsilateral cerebellar hemisphere.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inhibitory cerebral rTMS group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients underwent 10 consecutive daily sessions of continous theta bust stimulation (cTBS) over the unaffected primary motor cortex of the hand and sham rTMS over the ipsilateral cerebellar hemisphere.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Repetitive transcranial magnetic stimulation</intervention_name>
    <description>rTMS over cerebral motor cortex and cerebellar hemisphere</description>
    <arm_group_label>Facilitatory cerebral and cerebellar rTMS group</arm_group_label>
    <arm_group_label>Facilitatory cerebral rTMS group</arm_group_label>
    <arm_group_label>Inhibitory cerebral and cerebellar rTMS group</arm_group_label>
    <arm_group_label>Inhibitory cerebral rTMS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hemiplegic stroke patients within 1 month after onset&#xD;
&#xD;
          -  Moderate to severe motor impairment (Fugl-Meyer assessment &lt;85)&#xD;
&#xD;
          -  Cognitive and language functions to perform more than one step of command&#xD;
&#xD;
          -  More than 19 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindicated to rTMS&#xD;
&#xD;
          -  Progressive or unstable stroke&#xD;
&#xD;
          -  Pre-existing and active major neurological disease or major psychiatric disease&#xD;
&#xD;
          -  A history of advanced liver, kidney, cardiac or pulmonary disease, a terminal medical&#xD;
             diagnosis consistent with survival &lt;1 year&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Won Hyuk Chang, MD.,PhD.</last_name>
    <phone>82-2-3410-6068</phone>
    <email>wh.chang@samsung.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>06351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Won Hyuk Chang, Prof</last_name>
      <phone>82-2-3410-6068</phone>
      <email>wh.chang@samsung.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>06351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Won Hyuk Chang, MD., PhD.</last_name>
      <phone>82-2-3410-6068</phone>
      <email>wh.chang@samsung.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 21, 2020</study_first_submitted>
  <study_first_submitted_qc>September 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2020</study_first_posted>
  <last_update_submitted>October 3, 2020</last_update_submitted>
  <last_update_submitted_qc>October 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Won Hyuk Chang</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The data that support the findings of this study will be available from the principal investigator upon reasonable request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

